|
|
Thomson Financial Business Description:
| The Group's principal activity is to invent, develop and market drugs. The Group focuses on research and development of drugs, primarily targeting diseases related to the central nervous system. The products of the Group are sold mainly to the pharmaceutical industry and later on to patients suffering from diseases that are highly disabling such as ADHD, anxiety disorders, cancer, COPD, depression, epilepsy, pain and Parkinson's disease. The Group's research has also led to research and development projects related to other diseases such as obesity, cancer, urinary incontinence and certain heart diseases. |
|
Alacra Alerts:
|
Receive alerts on the latest reports on NeuroSearch A/S
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
|
|